Search

Kwon Yon Musick

from Lakewood Ranch, FL
Age ~62

Kwon Musick Phones & Addresses

  • 6622 The Masters Ave, Lakewood Rch, FL 34202
  • Lakewood Ranch, FL
  • Cincinnati, OH
  • Marshalls Creek, PA
  • East Stroudsburg, PA
  • Sarasota, FL
  • Lexington, MA
  • Bridgewater, NJ
  • Somerville, NJ
  • Villa Grove, CO

Publications

Us Patents

Thienopyrazoles

View page
US Patent:
7518000, Apr 14, 2009
Filed:
Mar 6, 2006
Appl. No.:
11/368566
Inventors:
John Gerald Jurcak - Bethlehem PA, US
Matthieu Barrague - Hoboken NJ, US
Timothy Alan Gillespy - Hillsborough NJ, US
Michael Louis Edwards - Morristown NJ, US
Kwon Yon Musick - Raritan NJ, US
Phillip Marvin Weintraub - Warren NJ, US
Yan Du - Bridgewater NJ, US
Ramalinga M. Dharanipragada - Belle Mead NJ, US
Ashfaq Ahmed Parkar - Piscataway NJ, US
Assignee:
Aventis Pharmaceuticals, Inc. - Bridgewater NJ
International Classification:
C07D 495/02
C07D 231/54
US Classification:
549 50, 5483605
Abstract:
Thienopyrazoles of formula I, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical uses in the treatment of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK).

Thienopyrazoles

View page
US Patent:
7928231, Apr 19, 2011
Filed:
Mar 26, 2009
Appl. No.:
12/411818
Inventors:
John Gerard Jurcak - Bethlehem PA, US
Matthieu Barrague - North Brunswick NJ, US
Timothy Alan Gillespy - Hillsborough NJ, US
Michael Louis Edwards - Suffolk VA, US
Kwon Yon Musick - Bridgewater NJ, US
Philip Marvin Weintraub - Warren NJ, US
Yan Du - Bridgewater NJ, US
Ramalinga M. Dharanipragada - Belle Mead NJ, US
Ashfaq Ahmad Parkar - Princeton NJ, US
Assignee:
Aventis Pharmaceuticals Inc. - Bridgewater NJ
International Classification:
C07D 403/00
C07D 231/54
US Classification:
544364, 544371, 5483605
Abstract:
Thienopyrazoles of formula I, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical uses in the treatment of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK).

Indole Derivatives As Interleukin -4 Gene Expression Inhibitors

View page
US Patent:
20040010029, Jan 15, 2004
Filed:
Apr 23, 2003
Appl. No.:
10/421511
Inventors:
Gregory Merriman - Phillipsburg NJ, US
Philip Weintraub - Warren NJ, US
Jeffrey Sabol - Bridgewater NJ, US
Ramalinga Dharanipragada - Belle Mead NJ, US
Nicholas Hrib - Hillsborough NJ, US
John Jurcak - Bethlehem PA, US
Alexandre Gross - Jersey City NJ, US
Brian Whiteley - Lebanon NJ, US
Kwon Musick - Raritan NJ, US
Joseph Klein - Neshanic Station NJ, US
International Classification:
C07D333/72
C07D209/42
A61K031/405
A61K031/381
US Classification:
514/419000, 514/443000, 548/492000, 549/055000
Abstract:
This invention discloses and claims a new class of indole derivatives for use in treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and diseases associated with bacterial, rhinovirus or respiratory syncytial virus (RSV) infections. It has now been found that the compounds of this invention are capable of modulating T helper (Th) cells, Th1/Th2, and thereby capable of inhibiting the transcription of interleukin-4 (IL-4) message, IL-4 release or IL-4 production.
Kwon Yon Musick from Lakewood Ranch, FL, age ~62 Get Report